26
Participants
Start Date
June 12, 2006
Primary Completion Date
January 17, 2007
Study Completion Date
January 31, 2008
Intravenous Artesunate
Three doses of Intravenous Artesunate drug at 2, 4, or 8 mg/kg in diluent Phosphate Buffer (0.3 M, pH 8.1)
Placebo
Mannitol (200 mg/vial) diluted in Phosphate Buffer and given IV in equivalent volume by subject's weight.
Uniformed Services University of the HEalth Sciences, Bethesda
Walter Reed Army Institute of Research (WRAIR)
FED
U.S. Army Medical Research and Development Command
FED